Brittany buys ENDP 63.75: Endo Pharmaceuticals Earnings Review: 16 Days after Announcement Shares Down 6.4% (ENDP)
16 days ago, on July 31st, 2014, Endo Pharmaceuticals (NASDAQ:ENDP) reported its earnings. Analysts, on average, expected earnings of $0.89 per share on sales of $647.4 million. Endo Pharmaceuticals actually reported earnings of $1.06 per share on sales of ... ...
19 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home